期刊
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
卷 150, 期 6, 页码 1517-1522出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jtcvs.2015.08.092
关键词
lung cancer; breath analysis
资金
- Clinical and Translational Science Pilot Grant Program (CTSPGP) of the University of Louisville
- National Science Foundation [CBET: 1159829]
- University of Louisville Coulter Grant Program
- Bill and Melinda Gates Foundation [OPP1039676]
- Bill and Melinda Gates Foundation [OPP1039676] Funding Source: Bill and Melinda Gates Foundation
- Directorate For Engineering
- Div Of Chem, Bioeng, Env, & Transp Sys [1159829] Funding Source: National Science Foundation
Objective: Several volatile carbonyl compounds in exhaled breath have been identified as cancer-specific markers. The potential for these markers to serve as a screening test for lung cancer is reported. Methods: Patients with computed tomography-detected intrathoracic lesions and healthy control participants were enrolled from 2011 onward. One liter of breath was collected from a single exhalation from each participant. The contents were evacuated over a silicon microchip, captured by oximation reaction, and analyzed by mass spectrometry. Concentrations of 2-butanone, 3-hydroxy-2-butanone, 2-hydroxyacetaldehyde, and 4-hydroxyhexanal were measured. The overall population was divided into 3 groups: those with lung cancer, benign disease, and healthy controls. An elevated cancer marker was defined as >= 1.5 SDs above the mean concentration of the control population. One or more elevated cancer markers constituted a positive breath test. Results: In all, 156 subjects had lung cancer, 65 had benign disease, and 194 were healthy controls. A total of 103 (66.0%) lung cancer patients were early stage (stage 0, I, and II). For >= 1 elevated cancer marker, breath analysis showed a sensitivity of 93.6%, and a specificity of 85.6% for lung cancer patients. Additionally, 83.7% of stage I tumors <= 2 cm were detected; whereas only 14% of the control population tested positive. In a comparison of cancer to benign disease, specificity was proportional to the number of elevated cancer markers present. Conclusions: Screening using a low-dose CT scan is associated with high cost, repeated radiation exposure, and low accrual. The high sensitivity, convenience, and low cost of breath analysis for carbonyl cancer markers suggests that it has the potential to become a primary screening modality for lung cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据